Now available!  Asian Biotechnology Venture Capital Directory.
2008. 

Produced by BioAblity and published by BioWorld Today, the 2008 Asia Pacific Biotechnology VC Directory provides the most accurate and current profiles available of VC firms in the Asia Pacific region that are investing in the biotech industry. At 100 pages, you can quickly identify and learn about the VCs you should contact for your funding search.

This directory provides an excellent resource for biotechnology firms at any funding-stage: Seed, Series A-B, Series C-D, Mezzanine, Bridge, and Buyout. More than 100 VC firms are profiled at over 240 locations. Multiple contacts are included for most firms, with direct contact details, including e-mail addresses.

Also included is an index of biotechnology companies with their corresponding VC partners, allowing you to target VCs that are investing in similar companies.

With this directory, you will be able to:

Any biotechnology company doing business today must consider itself a global company from day one, and no other region is garnering as much attention for its investment potential as Asia. Navigating a funding search in Asia is a complicated task, which is why the 2008 Asia Pacific Biotechnology VC Directory is a must-have for any company going in that direction.

This report can be purchased in print or PDF.  $599.  TO Order from BioWorld Publications, click here.

You can also order the data contained in this report in electronic (MS Access or Excel format for $490).  Click here for details

Also Available:
2007 U.S. , Canadian, and European Biotechnology VC Directory: Venture Capital Firms and Contacts

This is the only directory available for researching the niche segment of VC firms in the U.S., Canada and Europe that invest in biotechnology companies. It provides an excellent resource for any biotechnology company looking for various stages of funding: Seed, Series A-B, Series C-D, Mezzanine, Bridge, and Buyout.

The number of VC contacts you will find in the 2007 Biotechnology VC Directory

In Print, $599.  Available from BioWorld Today.  To order, click here.

To order the North American, European and or Asian VC data as a database in MS Excel or Access format, click here.

 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _

2007 U.S. and Canadian Medical Devices VC Directory: Venture Capital Firms and Contacts

Completely updated for 2007 and now including Canadian venture capital firms investing in medical device companies! This directory is published by BioWorld and includes information on over 500 venture capital firms investing in medical device companies.  Where available, this directory provides information on the following:

·        Funding stages each firm invests in

·        Focus areas of investment

·        Companies funded by each firm

For Information or ordering click here.

Biodefense and Homeland Security Reports

Two 2006 reports analyzing the current markets and competition for vaccines, therapeutics, diagnostics, and also the funding opportunities available for biodefense and homeland security

BioAbility has been involved in data collection, analysis, and report writing related to biodefense since 2001.

Biodefense Market Report: Vaccines, Therapeutics and Diagnostics for Bioterror Agents 2006

          ·        250 pages - 15% larger than 2005 edition.

·        Expanded profiles of products for SARS

·        Current products in development for avian influenza

·        Added section on diagnostics products and technologies

·        Market size analysis for various diseases

·        Details and status on 158 bioterror vaccines and 155 therapeutics

For details on this report and ordering, click here. 

 ***************************************

BioDefense and Homeland Security:  Opportunities for Life Science Companies 2006: Biodefense and Homeland Security: Opportunities for Life Science Companies 2006 is a new resource guide for companies trying to succeed in the biodefense industry!

At 273 pages, this Guide is 25 percent larger than our previous edition. The Biodefense and Homeland Security guide steers you through the labyrinth of opportunities, programs and procedures in the emerging biodefense industry. With a strong focus on actual companies that have become successful in biodefense, this report has become a valuable resource to many companies pursuing opportunities in this market. 

For details on this report and ordering, click here.

To order or for more information regarding these publications, contact BioAbility at 919.544.5111 info@bioability.com.